These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 2751745)

  • 21. Serum lipoproteins in patients with myocardial infarction.
    Kauppinen-Mäkelin R; Nikkilä EA
    Atherosclerosis; 1988 Nov; 74(1-2):65-74. PubMed ID: 3214482
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Study of lipids (cholesterol, triglycerides and phospholipids), plasma lipoproteins (HDL-cholesterol) and apoproteins (apo A and apo B in patients with acute myocardial infarction].
    Paniagua J; Martínez Muñoz A; Tuset N; Gras J
    Med Clin (Barc); 1989 Jun; 93(4):134-8. PubMed ID: 2796436
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interstitial fluid apolipoprotein A-II: an association with the occurrence of myocardial infarction.
    Luc G; Majd Z; Poulain P; Elkhalil L; Fruchart JC
    Atherosclerosis; 1996 Nov; 127(1):131-7. PubMed ID: 9006813
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of niceritrol (pentaerythritol tetranicotinate) on plasma lipoprotein concentration: increment of high density lipoprotein(HDL) cholesterol and HDL-cholesterol/low density lipoprotein cholesterol ratio in hypo-high density lipoproteinemia.
    Oida K; Nakai T; Tamai T; Kutsumi Y; Kobayashi T; Hayashi T; Yamada S; Takeda R
    Artery; 1982; 10(4):266-85. PubMed ID: 7181672
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of desogestrel and gestodene in low-dose oral contraceptive combinations on lipid and lipoprotein status. A randomized prospective study.
    Granata A; Sobbrio GA; D'Arrigo F; Barillari M; Curasì MP; Egitto M; Trimarchi F; Granese D; Pullè C
    Acta Eur Fertil; 1990; 21(3):143-6. PubMed ID: 2149913
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metabolic effects of a biphasic oral contraceptive preparation containing ethinyloestradiol and desogestrel on serum lipoproteins and apolipoproteins.
    Voorhoof L; Rosseneu M; Caster H; De Keersgieter W
    J Endocrinol; 1986 Oct; 111(1):191-6. PubMed ID: 2946795
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Are apolipoproteins A and B better than lipoproteins for assessing risk of obstructive coronary heart disease?
    Manfroi WC; Zago AJ; Campos M; Alves A; Brisolara ML; de Souza J; Candiago RH; Kirschnick L; Ribeiro L; Ordovás K; Leitão C; Cruz R
    Arq Bras Cardiol; 1999 Jun; 72(6):657-68. PubMed ID: 10752172
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Total plasma apo E and high density lipoprotein apo E in survivors of myocardial infarction.
    Bittolo Bon G; Cazzolato G; Saccardi M; Kostner GM; Avogaro P
    Atherosclerosis; 1984 Oct; 53(1):69-75. PubMed ID: 6497945
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A prospective study of cholesterol, apolipoproteins, and the risk of myocardial infarction.
    Stampfer MJ; Sacks FM; Salvini S; Willett WC; Hennekens CH
    N Engl J Med; 1991 Aug; 325(6):373-81. PubMed ID: 2062328
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Levels of lipoprotein and homocysteine in non-obese and obese patients with polycystic ovary syndrome.
    Yilmaz M; Biri A; Bukan N; Karakoç A; Sancak B; Törüner F; Paşaoğlu H
    Gynecol Endocrinol; 2005 May; 20(5):258-63. PubMed ID: 16019370
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lipids, lipoproteins, apolipoproteins, and other risk factors in Chinese men and women with and without myocardial infarction.
    Schwartzkopff W; Schleicher J; Pottins I; Yu SB; Han CZ; Du DY
    Atherosclerosis; 1990 Jun; 82(3):253-9. PubMed ID: 2375789
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increased frequency of lipoprotein disorders similar to type III hyperlipoproteinemia in survivors of myocardial infarction in Japan.
    Kameda K; Matsuzawa Y; Kubo M; Ishikawa K; Maejima I; Yamamura T; Yamamoto A; Tarui S
    Atherosclerosis; 1984; 51(2-3):241-9. PubMed ID: 6743382
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of fluvastatin on intermediate density lipoprotein (remnants) and other lipoprotein levels in hypercholesterolemia.
    Broyles FE; Walden CE; Hunninghake DB; Hill-Williams D; Knopp RH
    Am J Cardiol; 1995 Jul; 76(2):129A-135A. PubMed ID: 7604788
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Postprandial remnant-like lipoproteins in hypertriglyceridemia.
    Ooi TC; Cousins M; Ooi DS; Steiner G; Uffelman KD; Nakajima K; Simo IE
    J Clin Endocrinol Metab; 2001 Jul; 86(7):3134-42. PubMed ID: 11443178
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Heparin-released plasma lipase activities, lipoprotein and apoprotein levels in young adult cyclists and sedentary men.
    Giada F; Baldo-Enzi G; Balocchi MR; Zuliani G; Baroni L; Fellin R
    Int J Sports Med; 1988 Aug; 9(4):270-4. PubMed ID: 3141306
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A two-year clinical study of the effects of two triphasic oral contraceptives on plasma lipids.
    Kakis G; Powell M; Marshall A; Woutersz TB; Steiner G
    Int J Fertil Menopausal Stud; 1994; 39(5):283-91. PubMed ID: 7820162
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lipid and apoprotein modifications in body builders during and after self-administration of anabolic steroids.
    Baldo-Enzi G; Giada F; Zuliani G; Baroni L; Vitale E; Enzi G; Magnanini P; Fellin R
    Metabolism; 1990 Feb; 39(2):203-8. PubMed ID: 2105436
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of androgenic-anabolic steroids on apolipoproteins and lipoprotein (a).
    Hartgens F; Rietjens G; Keizer HA; Kuipers H; Wolffenbuttel BH
    Br J Sports Med; 2004 Jun; 38(3):253-9. PubMed ID: 15155420
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Apolipoprotein B-containing lipoproteins in renal failure: the relation to mode of dialysis.
    Attman PO; Samuelsson OG; Moberly J; Johansson AC; Ljungman S; Weiss LG; Knight-Gibson C; Alaupovic P
    Kidney Int; 1999 Apr; 55(4):1536-42. PubMed ID: 10201020
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Apolipoprotein B metabolism in subjects with deficiency of apolipoproteins CIII and AI. Evidence that apolipoprotein CIII inhibits catabolism of triglyceride-rich lipoproteins by lipoprotein lipase in vivo.
    Ginsberg HN; Le NA; Goldberg IJ; Gibson JC; Rubinstein A; Wang-Iverson P; Norum R; Brown WV
    J Clin Invest; 1986 Nov; 78(5):1287-95. PubMed ID: 3095375
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.